Sergi Ferré

25.2k total citations · 2 hit papers
287 papers, 20.3k citations indexed

About

Sergi Ferré is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Sergi Ferré has authored 287 papers receiving a total of 20.3k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Cellular and Molecular Neuroscience, 176 papers in Molecular Biology and 109 papers in Physiology. Recurrent topics in Sergi Ferré's work include Receptor Mechanisms and Signaling (160 papers), Adenosine and Purinergic Signaling (109 papers) and Neuroscience and Neuropharmacology Research (88 papers). Sergi Ferré is often cited by papers focused on Receptor Mechanisms and Signaling (160 papers), Adenosine and Purinergic Signaling (109 papers) and Neuroscience and Neuropharmacology Research (88 papers). Sergi Ferré collaborates with scholars based in United States, Spain and Sweden. Sergi Ferré's co-authors include Kjell Fuxé, Rafael Franco, Carme Lluı́s, Vicent Casadó, Luigi F. Agnati, Francisco Ciruela, Patrizia Popoli, Enric I. Canela, Bertil B. Fredholm and Steven R. Goldberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Sergi Ferré

283 papers receiving 19.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia

1997 679 citations Sergi Ferré, Kjell Fuxé et al. profile →
G Protein–Coupled Receptor Oligomerization Revisited: Functional and Pharmacological Perspectives

2014 454 citations Sergi Ferré, Vicent Casadó et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sergi Ferré United States	81	11.5k	10.5k	6.7k	2.8k	2.4k	287	20.3k
Rodrigo A. Cunha Portugal	79	9.0k 0.8×	5.9k 0.6×	10.3k 1.5×	1.6k 0.6×	2.4k 1.0×	339	20.3k
Michael W. Salter Canada	74	12.3k 1.1×	9.4k 0.9×	2.1k 0.3×	1.7k 0.6×	2.2k 0.9×	180	25.1k
John W. Phillis United States	71	9.9k 0.9×	6.9k 0.7×	3.5k 0.5×	1.2k 0.4×	1.0k 0.4×	364	16.9k
Bertil B. Fredholm Sweden	93	12.8k 1.1×	13.9k 1.3×	18.9k 2.8×	1.9k 0.7×	3.1k 1.3×	528	36.2k
Trevor W. Stone United Kingdom	66	6.8k 0.6×	6.4k 0.6×	2.5k 0.4×	1.1k 0.4×	899 0.4×	433	17.8k
Steven R. Goldberg United States	73	11.8k 1.0×	6.9k 0.7×	1.5k 0.2×	644 0.2×	5.1k 2.1×	218	16.8k
Catherine Ledent Belgium	69	11.5k 1.0×	4.3k 0.4×	3.1k 0.5×	691 0.2×	9.9k 4.2×	253	20.1k
Mike Dragunow New Zealand	72	9.2k 0.8×	7.4k 0.7×	754 0.1×	2.2k 0.8×	1.1k 0.5×	231	18.2k
Ana M. Sebastião Portugal	58	4.9k 0.4×	3.4k 0.3×	4.4k 0.7×	957 0.3×	924 0.4×	241	10.2k
Francisco Ciruela Spain	62	6.4k 0.6×	7.2k 0.7×	3.3k 0.5×	752 0.3×	724 0.3×	261	11.3k

Countries citing papers authored by Sergi Ferré

Since Specialization

Citations

This map shows the geographic impact of Sergi Ferré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergi Ferré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergi Ferré more than expected).

Fields of papers citing papers by Sergi Ferré

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergi Ferré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergi Ferré. The network helps show where Sergi Ferré may publish in the future.

Co-authorship network of co-authors of Sergi Ferré

This figure shows the co-authorship network connecting the top 25 collaborators of Sergi Ferré. A scholar is included among the top collaborators of Sergi Ferré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergi Ferré. Sergi Ferré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moreno, Estefanía, César Quiroz, Vicent Casadó, et al.. (2025). Distinctive biochemical properties of the μ-opioid receptor-corticotropin- releasing factor CRF1 receptor heterotetramer. Pharmacological Research. 219. 107904–107904. 1 indexed citations

Yang, Tianxin, Mingyang Yuan, Matilde Inglese, et al.. (2025). Development of a HiBiT Peptide-Based NanoBRET Ligand Binding Assay for Galanin Receptor 1 in Live Cells. ACS Chemical Biology. 20(7). 1594–1608. 1 indexed citations

Ferré, Sergi, Diego García‐Borreguero, & C EARLEY. (2025). On the mechanisms of dopamine receptor agonists in restless legs syndrome. SLEEP. 49(1).

Levinstein, Marjorie R., Paulo Alexandre de Oliveira, César Quiroz, et al.. (2023). Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone. Molecular Psychiatry. 29(3). 624–632. 7 indexed citations

Ferré, Sergi, Attila Köfalvi, Francisco Ciruela, Zuzana Justinová, & Marco Pistis. (2023). Targeting corticostriatal transmission for the treatment of cannabinoid use disorder. Trends in Pharmacological Sciences. 44(8). 495–506. 6 indexed citations

Pulido, Daniel, Verònica Casadó-Anguera, Estefanía Moreno, et al.. (2022). Heterobivalent Ligand for the Adenosine A_2A–Dopamine D₂ Receptor Heteromer. Journal of Medicinal Chemistry. 65(1). 616–632. 13 indexed citations

Foster, Stephanie L., et al.. (2021). Cell‐type specific expression and behavioral impact of galanin and GalR1 in the locus coeruleus during opioid withdrawal. Addiction Biology. 26(5). e13037–e13037. 7 indexed citations

Navarro, Gemma, William Rea, César Quiroz, et al.. (2021). Complexes of Ghrelin GHS-R1a, GHS-R1b, and Dopamine D₁Receptors Localized in the Ventral Tegmental Area as Main Mediators of the Dopaminergic Effects of Ghrelin. Journal of Neuroscience. 42(6). 940–953. 16 indexed citations

Callado, Luís F., Ester Aso, Kristoffer Sahlholm, et al.. (2020). Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia. Neuropsychopharmacology. 46(3). 665–672. 30 indexed citations

10.

Adrover, Martín F., Jung Hoon Shin, César Quiroz, et al.. (2020). Prefrontal Cortex-Driven Dopamine Signals in the Striatum Show Unique Spatial and Pharmacological Properties. Journal of Neuroscience. 40(39). 7510–7522. 31 indexed citations

11.

Ma, Liangsuo, Joel L. Steinberg, James M. Bjork, et al.. (2018). Fronto-striatal effective connectivity of working memory in adults with cannabis use disorder. Psychiatry Research Neuroimaging. 278. 21–34. 20 indexed citations

12.

Moreno, Estefanía, David Moreno‐Delgado, Gemma Navarro, et al.. (2014). Cocaine Disrupts Histamine H₃Receptor Modulation of Dopamine D₁Receptor Signaling: σ₁-D₁-H₃Receptor Complexes as Key Targets for Reducing Cocaine's Effects. Journal of Neuroscience. 34(10). 3545–3558. 59 indexed citations

13.

Ferré, Sergi. (2013). Caffeine and Substance Use Disorders. PubMed. 3(2). 57–58. 17 indexed citations

14.

Ferré, Sergi, Marco Orrù, & Xavier Guitart. (2013). Paraxanthine: Connecting Caffeine to Nitric Oxide Neurotransmission. PubMed. 3(2). 72–78. 15 indexed citations

15.

Ferré, Sergi & Mary Claire O’Brien. (2011). Alcohol and Caffeine: The Perfect Storm. PubMed. 1(3). 153–162. 57 indexed citations

16.

Moreno, Estefanía, Sandra H. Vaz, Ning-Sheng Cai, et al.. (2011). Dopamine–Galanin Receptor Heteromers Modulate Cholinergic Neurotransmission in the Rat Ventral Hippocampus. Journal of Neuroscience. 31(20). 7412–7423. 24 indexed citations

17.

Moreno, Estefanía, Hanne M. Hoffmann, Marta González-Sepúlveda, et al.. (2010). Dopamine D1-histamine H3 Receptor Heteromers Provide a Selective Link to MAPK Signaling in GABAergic Neurons of the Direct Striatal Pathway. Journal of Biological Chemistry. 286(7). 5846–5854. 99 indexed citations

18.

Ferré, Sergi, Gemma Navarro, Vicent Casadó, et al.. (2010). G Protein-Coupled Receptor Heteromers as New Targets for Drug Development. Progress in molecular biology and translational science. 91. 41–52. 41 indexed citations

19.

Marcellino, Daniel, Sergi Ferré, Vicent Casadó, et al.. (2008). Identification of Dopamine D1–D3 Receptor Heteromers. Journal of Biological Chemistry. 283(38). 26016–26025. 193 indexed citations

20.

Casadó, Vicent, Michael Bäder, Steven P. Goldberg, et al.. (2004). Combining Mass Spectrometry and Pull-Down Techniques for the Study of Receptor Heteromerization. Analytical Chemistry. 5354–5363. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact